Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12608000078358
ACTRN12608000078358
Completed
Phase 3

A randomised controlled study on Healthy Individuals to evaluate the efficacy of glyco-nutrient therapy compared to placebo on antioxidant and various immune cell functions with end of study outcomes.

Mannatech, Inc0 sites60 target enrollmentFebruary 13, 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsImmune system function in healthy individualsAntioxidant levels in healthy individualsInflammatory and Immune System - Normal development and function of the immune systemAlternative and Complementary Medicine - Herbal remedies

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Immune system function in healthy individuals
Sponsor
Mannatech, Inc
Enrollment
60
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 13, 2008
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Mannatech, Inc

Eligibility Criteria

Inclusion Criteria

  • •Individuals willing to cease all medications over the course of the study, excluding medications for acute conditions such as pain or dyspepsia.

Exclusion Criteria

  • •Individuals taking antioxidant medications and/or supplements. Individuals with poor venous access. Individuals with auto\-immune disorders or an immune disease. Individuals taking steroid medication or non steroidal anti\-inflammatory drugs (NSAID) treatments. Individuals with diabetes. Individuals taking anticoagulants. Individuals taking immune suppressant drugs. Individuals taking cytokine or interferon therapy. Individuals taking Echinacea or other immune stimulating herbs. Individuals with clinically abnormal liver function tests at baseline. Individuals who develop a cold or other acute upper respiratory tract infection (URTI) or influenza during the course of the study. Individuals unwilling to have blood taken 6 times during the study. Individuals unwilling to comply with the study protocols. Individuals with any other condition which in the opinion of the researchers could compromise the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 1
Trial of swine influenza vaccine in healthy adultsSwine influenzaInfection - Other infectious diseases
ACTRN12609000674235Vaxine Pty Ltd300
Completed
Phase 1
Safety study of an improved aluminium-free Hepatitis B vaccine based on a natural plant sugarHepatitis B preventionInfection - Other infectious diseasesPublic Health - Epidemiology
ACTRN12607000598482Vaxine Pty Ltd24
Recruiting
Phase 1
A Randomized Controlled Study on the Health Intervention of Duanjin Exercise on Patients with Chronic Heart FailureChronic heart failure
ITMCTR2200005717Shandong university of traditional Chinese medicine
Recruiting
Not Applicable
Trialing a fruit and vegetable intervention to promote a healthy weight and reduce disease riskPoor dietary intakeDiet and Nutrition - Other diet and nutrition disorders
ACTRN12619001415190The University of Newcastle120
Active, not recruiting
Phase 1
Bioavailability study with LCZ696Study in healthy subjectsTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2017-001803-57-Outside-EU/EEAovartis Pharmaceuticals Corp40